Strategies for Disclosing HIV Status
Dr. Marguerita Lightfoot talks to WebMD about how to discuss one's HIV status with friends, family, and partners.
How People with Weakened Immune Systems Navigate the Coronavirus
Dr. Paul Volberding spoke to NPR about considerations for those with compromised immune systems.
Limited Information about COVID19 Impact on those Living with HIV
Data doesn't yet exist to understand how HIV status may impact HIV+ individuals, says Dr. Matt Spinelli, but there are recommendations.
COVID19 Adds Complications for Cancer Patients
Take extra care for those living with advanced cancer, explains Dr. Paul Volberding.
New First Line Therapy Recommendation Criticized by UCSF Expert
Dr. Monica Gandhi of the Division of HIV/ID warns against possible drug resistance and other concerns in an interview with the SF AIDS Foundation.
Recurring Syphilis Cases Call for New Strategies
ARI Director comments to Healio why the surge in reinfections occurs and how to prevent them.
FDA Rejection of Injectable Antiretroviral Treatment Likely a Technicality
Dr. Volberding talks to The Body Pro about reasons for denying the approval of the long-awaited advancement.
UCSF Pathology Professor Encourages Red Cross Pressure on the FDA Regarding Blood Donations
Speaking to Yahoo News, Dr. Brian Custer explains why outdated policies around gay men donating blood need to be updated.
Dr. Tim Henrich Assuages Concern Around New Strain of HIV
An interesting finding with likely little clinical significance, he explains to Salon.
A&U Features Mosaico Vaccine Trial Goals and Potential Outcomes
Dr. Susan Buchbinder spoke to the magazine about the global vaccine with a site here in San Francisco.
ARI Director Offers Insight into New Latency Findings
Healio features Dr. Paul Volberding's perspective on virus latency findings recently released in Science Translational Medicine.
ID Week Coverage Highlights UCSF Experts' Commentary on Novel HIV Therapies
Two-drug therapy and long-acting injectables dominated coverage from ARI experts.
UCSF Physician Scientist Steve Deeks Speaks to the "San Francisco Patient"
Dr. Deeks describes Loreen Willenberg, an elite controller of the virus, as impossible to forget.
AIDS2020 Press Conference Kicks off Registration, Featuring Co-Chair Dr. Monica Gandhi
Welcoming attendees to the Bay Are next summer, Speaker Nancy Pelosi and Congresswoman Barbara Lee touched upon the history of HIV in the SF and Oakland.
Grindr Poses Great Prevention Opportunity for App Users
CFAR Director Dr. Monica Gandhi notes that the app can be a way to reach particularly vulnerable populations at risk for HIV.
Dr. Volberding Weighs in on Adult Film Industry's Safety Frameworks
ARI Director says viral load suppression and PrEP makes separate testing protocols and limitations unnecessary for HIV-positive performers.
Breakthrough HIV Vaccine Trial led by UCSF-DPH Physician Highlighted by LA Times
Dr. Susan Buchbinder details how the Phase 3 trial rolls out during a critical point in the fight against the epidemic.
Amid Pricing Concerns for Descovy, ARI Director Weighs In
More options for PrEP, including generics, benefit those with a range of insurance plans, says Dr. Volberding.
SFDPH Physician and UCSF Professor Dr. Susan Buchbinder Discusses a Phase 3 Vaccine Trial
The trial, starting in September, will enroll 3,800 participants in San Francisco.
Senior Fellow in Division of HIV Reveals Major Disparity in Mortality for Homeless Recently Diagnosed HIV-positive
Dr. Matt Spinelli shows a 27-fold greater risk of dying for those without housing following HIV diagnosis.
NPR's Fresh Air Talks to Leaders of SF General and UCSF's Pioneering AIDS Ward
As Pride Month Begins in San Francisco, Volberding Reflects on the Early Days
Recalling the emergence of AIDS in 1980s SF, ARI Director is celebrated as a pioneer in the field.
Good News for PrEP Users about Bone Density Found by UCSF Researchers
Though loss of density can occur with regular use, discontinuation reverses the trend - one of many findings of a multi-country study led by Dr. Michael Spinelli.
NPR Features Expert Panel Led by UCSF and DPH Physicians Recommends Wider Use of PrEP
Dr. Hyman Scott talks to All Things Considered about increasing availability and uptake of the drug to prevent new HIV transmission in high-risk groups.
Aging with HIV Poses Different Challenges, says ARI Director
Cardiovascular disease manifesting in those with HIV should receive increased attention, notes Dr. Paul Volberding in an interview with Reuters.
Long-Term Survivors Featured in Second Installment of Medscape TV Series
Staying Golden, a three part series focused on aging persons living with HIV celebrates the work of Drs. Meredith Greene, Steve Deeks, and Monica Gandhi in the UCSF Golden Compass program and pays special tribute to one of our longest patient relationships.
The Center for Strategic and International Studies Launches AIDS2020 Podcast with co-chair Monica Gandhi
AIDS2020 Seeks State Support for the 23rd International AIDS Conference
Bay Area Reporter details the rationale for State Senator Scott Wiener's appeal for $2 million in support from California for AIDS2020.
If Half of Those Living with HIV are Women, Why are the Vast Majority of Research Participants Men?
Dr. Gandhi explains the importance of involving women in groundbreaking HIV clinical trials to the New York Times.
What Can we Learn from Those Naturally Resistant to HIV?
Steve Deeks talks to Smithsonian about the key points on the virus that are weak to immune system attacks and can lead to potential vaccines or cure.
Director Dr. Paul Volberding and Ward86 Medical Director Dr. Monica Gandhi Discuss Evolution of UCSF Leadership in the Field
In interviews with Carry the One radio, Volberding and Gandhi showcase UCSF's influence from day 1 to today.
ARI Fellow Links Impact of Homelessness to Frequency of Acute Care Visits for those Living with HIV
Dr. Angelo Clemenzi-Allen talked to Healio about unstable housing and those seeking care in San Francisco.
JAMA Editorial Highlight Rise in STIs Among MSM Taking PrEP Profiled by MedPage Today
Dr. Monica Gandhi cautioned against interpreting these results in isolation.
Answering Essential Questions about Antiretrovirals in Pregnancy
In her profile at CROI, Dr. Monica Gandhi discusses what we still need to learn about pregnant women taking antiretroviral medication.
San Francisco's Model of Getting to Zero Continues to Lead the Nation in Reduction of Infections, Death, and Stigma
The LA Times profiled the work of the UCSF Division of HIV and the San Francisco General Hospital as they lead the country in efforts fighting the epidemic.
UCSF Investigator Sends Clarion Call for Ending TB
Dr. Mike Reid Tells MedPage Today that ending tuberculosis is in reach by 2045.
London Patient Indicates we are 'On the Right Track,' says Dr. Tim Henrich
In an interview with MedPage Today, Henrich dissects the key outcomes of the remission case and how it can influence cure research moving forward.
As World TB Day Looms, the Lancet Commission Emerges with UCSF Leadership
Golden Compass Serving Senior HIV Populations Profiled in Medscape TV
Drs. Steve Deeks, Monica Gandhi, and Meredith Greene discuss the clinical issues facing HIV populations and how UCSF supports the unique population.
NY Times References the Trauma-Informed Care Services of the UCSF Women's HIV Program Clinic
After being profiled in Health Affairs, the Times further highlights the importance of the work of Dr. Eddy Machtinger and team.
UCSF Investigators' Insights into Second 'Cure' Heavily Referenced at CROI 2019
Dominating coverage of this year's Conference on Retroviruses and Opportunistic Infections was news of the second patient to be reportedly cured of HIV. Before, during, and after the meeting, clinician-researchers spoke to the NY Times, CNN, MedPage Today, Healio, Wired, NPR, the SF Chronicle, and ABC News.
Researchers and Clinicians Look to UCSF Experts' Findings Exploring ART for Pregnant Women
Healio interviewed Dr. Monica Gandhi about her work presented at CROI looking to better understand how antiretroviral therapy affects pregnant women.
UCSF Global Health Experts Advise on Circumcision's Impact on HIV Transmission
In response to a new Netflix documentary opposing the procedure, Drs. Craig Cohen and George Rutherford spoke to MedPage Today about the benefits of voluntary male medical circumcision.
Pharmaceutical Commerce Highlights Insights from UCSF Investigators' Cure and PrEP Research
Dr. Steve Deeks spoke about advances in cure research, while Dr. Hyman Scott discussed PrEP successes and challenges.
Dr. Satish Pillai Addresses the Status of Cure Research with the Guardian
Referencing the "holy grail" for HIV, Dr. Pillai details how close we are to a cure.
ARI Director Speaks to China Gene-Editing Study with HIV Prevention Potential
Dr. Paul Volberding admitted to both ethical and research transparency concerns regarding the world's first gene-edited babies.
At HIV Glasgow, Dr. Deeks Talks Cure Strategy
MedPage Today highlights the combination approach needed to achieve the ultimate goal.
Drs. Greene, Deeks, and Volberding Talk HIV Cure Progress in SF Business Times
The interdisciplinary nature of the current cure research and clinical trial were emphasized by the three members of the amfAR Institute for HIV Cure Research.
Eric Goosby, UN Special Envoy on TB Discusses Importance of High-Level Meeting
The first UN high-level meeting dedicated to tuberculosis is key to spurring action in reducing TB rates, former Global AIDS Ambassador and PEPFAR coordinator Dr. Goosby tells WHO.
HIV Disparities Highlighted in California Health Report
Despite significant strides in reducing new HIV infections, troubling disparities remain, says Dr. Katerina Christopoulos.
Healio Features UCSF Food Insecurity and Inflammation in HIV+ Women Research
Drs. Sheri Weiser and Anna Leddy discussed their findings that HIV-positive individuals are more likely to experience food insecurity and related inflammation.
amfAR Institute Community Advisory Board Chair Profiled
Jeff Taylor, longtime community advocate and leader of the amfAR Institute for HIV Cure Research CAB is featured by amfAR's In the Community series.
UCSF Investigators and Interventions Featured Twice in Latest Issue of Annals of Internal Medicine
MedPage Today Highlights Work of 11 UCSF Researchers in Video Interviews at IAC 2018
The media channel showcased the work of leading clinicians at the International AIDS Conference in Amsterdam.
Golden Compass Shines in A&U
The magazine showcased the essential services Golden Compass offers for seniors living with HIV.
Healthline Promotes Buchbinder Participation in Vaccine Trial
The online news magazine quotes Dr. Buchbinder's reflections on the global network of researchers working towards a cure.
NPR Explores UCSF Food Insecurity Research
WBUR, Boston's NPR affiliate, spoke with Sheri Weiser about her work on food insecurity for those living with HIV.
Dr. Susan Buchbinder Speaks to Promising Results of HIV-1 Vaccine Trial
As co-chair of the phase IIb efficacy trial for the APPROACH study, Dr. Buchbinder highlighted in MedPage Today the promising foundation the results offer.
Division of Experimental Medicine's Tim Henrich Offers Insight on Treg Study
Dr. Henrich warned against extrapolating causation from correlation in MedPage Today in regards to study exploring Treg cells' potential role in preventing mother-to-child transmission of HIV.
NY Times Cites Dr. Paul Volberding in Discussion about PrEP Uptake Leading to Condom Use Decrease
The ARI Director commented on risk of other STIs as recent study shows condom use falling in Australia with the increase in PrEP use.
Dr. Peter Hunt Illuminates How "Public" T-Cell Receptors Fight HIV
The Scientist quotes Dr. Hunt's insight into how these receptors may forge a new path in immunotherapy.
CAPS Director Dr. Marguerita Lightfoot Talks to the New York Times about Outdated HIV in the Military Policies
In underscoring how the one pill a day regimen makes controlling the virus very easy, Lightfoot highlighted that stigma is what continues to drive discriminatory policies.
Steven Deeks Explains Sleeper Cells
Dr. Deeks discusses how HIV persists in the body with Nature Medicine.
ARI Director Dr. Paul Volberding Comments on Status of HIV Basic Science Research
In talking to MedPage Today, Volberding notes the difficulties and promises in the field.
SCOPE Program Director Rebecca Hoh, RD, Wins 2018 Holly Smith Award
The award is given to leaders exemplifying UCSF's mission - for 15 years, Hoh has advanced and integrated clinical HIV research at UCSF.
Dr. Paul Volberding Featured on UC Podcast Series "One Bold Idea"
The HIV physician was profiled for the pioneering work of Ward 86 in the 1980s, and its current status as one of the leading HIV clinics in the world.
Time Magazine Showcases HIV Cure Research Insight of UCSF's Dr. Steven Deeks
Underscoring what HIV researchers are learning from the oncology field, Dr. Deeks' expertise was quoted extensively.
UCSF and Gladstone Investigator Dr. Nadia Roan Featured on NIH Director's Blog
Dr. Roan, with appointments at both UCSF and Gladstone, has her work and micrograph imagery highlighted on Dr. Francis Collins' blog.
AIDS Map Highlights Dr. Monica Gandhi's Study Measuring ARV Levels in Hair
Daily Mail Promoted Dr. Steve Yukl's Groundbreaking Latency Study
The British periodical celebrated Yukl and team's new findings about how HIV hides in the body.
Dr. Judy Auerbach Speaks to Recent HIV and Depression Research
In talking to Reuters, Auerbach underscores needs for HIV care to incorporate more than ART.
UCSF and Gladstone Investigator Dr. Nadia Roan Profiled in SF Business Times
Highlighting her basic science training and projects, Roan was honored as a woman leading in life sciences in the Bay Area.
Dr. Bob Wachter Talks to Dr. Paul Volberding about the History of HIV at UCSF
On UCTV, Dr. Volberding details his personal and professional history within the University.
Dr. Monica Gandhi Comments to NPR about Once a Week HIV Treatment Study
In talking to NPR, the Medical Director of Ward 86 addressed treatment adherence as a key difficulty in HIV care.
Louisville Courier-Journal Cites Volberding Perspective on HIV Emergence in Opioid Crisis
Dr. Volberding speaks to how the diminishing visibility of HIV in the public eye, and assumptions of the incidence and prevalence of the virus, drive infections.
Leading Physician-Researchers Comment on CDC 'Word Ban'
ARI Director Dr. Paul Volberding was quoted by MedPage discussing the importance of communication with populations at highest-risk for some diseases.
Getting to Zero Consortium Highlights Progress on World AIDS Day
The Bay Area Reporter was at the event, which emphasized the message that "undetectable equals untransmittable."
Bay Area Reporter Covers 2017 Cure Summit
The press also detailed findings from Drs. Deeks and Henrich about early treatment impacting the size of the reservoir.
KQED Science Offers Hopeful Profile from 2017 Cure Summit
Highlighting the narrative of the ART treatment interrupted patient of Drs. Deeks and Henrich, KQED showcases the positive gains in HIV research made at November's Summit.
amfAR Recaps the 2017 Cure Summit
Detailing the major themes of the conference and showcasing its diversity, amfAR reports on the Summit's success.
A&U: America's AIDS Magazine Reports on 2017 Cure Summit
The article covered some of the challenges and victories - both social and scientific - discussed by the cure investigators at the November event.
Drs. Warner Greene and Judy Auerbach Comment on NIH Funding in HuffPo World AIDS Day Piece
Both the basic scientist and social scientist noted that in light of the NIH funding crisis and political decisions, the scientific HIV community is at risk and unfortunately competing with other industries for valuable money.
Dr. Steve Deeks in WAD PLOS Medicine Special Edition Editorial
Dr. Deeks, of the Division of HIV, Infectious Diseases, and Global Medicine, crafts an editorial in PLOS Medicine's special issue, Advances in HIV Prevention, Treatment and Cure, which he also guest edited. Read his and fellow guest editors' thoughts on nearing the end of AIDS on the PLOS Med site.
UCSF Global Health Works to End HIV in Tanzania
The Global Strategic Information group at UCSF IGHS manages large-scale surveillance to learn what drives the epidemic. Learn more at IGHS News.
Dr. Diane Havlir Wins Duke University Medical School 2017 Distinguished Alumna Award
UCSF Chief of the Division of HIV/AIDS, Infectious Disease, and Global Health receives award from her alma mater. Read about it on the Duke website.
UCSF Launches Capital Campaign and Highlights UCSF HIV Researchers and Clinicians
The campaign highlights the innovative work of UCSF teams, and celebrates the work of many of our HIV experts. At 2017's State of the University Address, UCSF's work towards eradicating HIV was also lauded.
PBS NewsHour Series on Ending AIDS Featuring UCSF HIV Faculty Experts Wins National Emmy
Ending AIDS highlights work being done domestically and abroad by UCSF investigators. Watch the clip of the award for Science, Medical, and Environmental Reporting.
HIV Medicine Association Honors Dr. Monica Gandhi as 2017 Clinical Educator and Research Leader
Dr. Gandhi is an internationally recognized clinician and educator who weaves teaching and mentoring into all aspects of her work. Read about this honor on the HIVMA site.
UCSF HIV Clinician Dr. Edward Machtinger Reframes HIV to Psychology Today
On National Gay Men's HIV/AIDS Awareness Day, the women's health, HIV, and trauma expert discusses the virus as a symptom of the results of trauma.
ARI Director Dr. Paul Volberding Talks to Rochester Post-Bulletin About Career in HIV
Detailing how he started his medical training in oncology and its development into his HIV expertise, he highlights the excitement around a cure. Read the whole article here.
New Funding Partnership for Reduced HIV Therapies Under Threat from U.S. Budget Cuts
ARI Director of Strategic Communications and Partnerships Dr. Larkin Callaghan and Division of HIV Clinical Fellow Dr. Mike Reid comment to the Independent on the importance of continued funding for HIV care abroad.
Aggressive Prevention Pays Off as New HIV Infections in SF Hit a Record Low
The San Francisco Chronicle highlights the work of multiple UCSF physicians as they report on decreasing HIV infections in the city.
UCSF HIV Researchers and Clinicians Work on Food Insecurity For Those with HIV in San Francisco
A team at ZSFGH led by Dr. Sheri Weiser and Dr. Kartika Palar focus on "food as medicine" for populations in need. Read the full story here.
Cutting U.S. Foreign Aid for HIV Would Cost Lives, Without Much Savings
Drs. Diane Havlir and Eric Goosby talk to Reuters about the costs for funding and their impact on new infections. Read the full story here.
Amy Lockwood Discusses New Threats to Global Health and the Role of Philanthropy
Lockwood's keynote at the Swedish Institute of International Affairs, Program on Global Politics and Security, was part of The Stockholm Act, a weeklong festival that brings together people from art, science, politics and business to explore the steps we can take to build a sustainable world. The whole keynote can be viewed on their site.
Drs. Paul Volberding and Peter Chin-Hong Comment to Healio about the Impact of Global Aid Cuts
Both physicians highlighted the impact that slashing foreign aid would have on HIV transmission and care after an Annals of Internal Medicine article laid out alternative HIV cutback strategies. Dr. Volberding also spoke to MedPage Today, and Dr. Eric Goosby to Medscape, about the prospects.
Dr. Monica Gandhi Explains the Meaning of 'Undetectable'
UCSF at IAS2017
UCSF brings strong showing to the 2017 International AIDS Conference. Read the details of our investigators' work presented here.
ARI Director Dr. Paul Volberding Featured in Documentary "HIV & AIDS Research - Its History and Future"
The film covers a meeting at Cold Spring Harbor Laboratory featuring some of the most prominent HIV researchers and clinicians in the world. Watch the video here.
UCSF Raises Over $100,000 for AIDS Walk SF 2017
Some of the funds will contribute to the UCSF Golden Compass program - read more at UCSF.
Every Step Forward: AIDS "Getting to Zero"
In Dr. Dan Lowenstein's Executive Vice Chancellor newsletter, he gives an overview of the current work being done by some of our leading investigators, including Drs. Paul Volberding, Diane Havlir, and Jay Levy.
UNAIDS Test and Treat Goals Surpassed in East Africa, Thanks to UCSF Researchers
UCSF Performs Pioneering Transplant Surgery from HIV+ Donor to HIV+ Recipient
Is There HIV in My Brain? UCSF Neurologist Dr. Joanna Hellmuth Fills Us in
Dr. Hellmuth talks to BetaBlog about how the virus works in the brain.
Diane Havlir on Nearing the End of HIV/AIDS
Dr. Havlir spoke about SF's coordinated efforts at Fortune’s Brainstorm Health Conference on May 2. Read the full story on UCSF.
Jeff Sheehy, of UCSF AIDS Research Institute, Appointed as San Francisco Supervisor
Read the full story on UCSF.
HIV Cure Summit
Watch the community update on progress toward an HIV cure, featuring ARI researchers, here.
Getting to Zero World AIDS Day Event
CAPS Turns 30
UCSF's Center for AIDS Prevention conducts cutting-edge prevention research to help end the AIDS epidemic.
UCSF Is Top Team for AIDS Walk
UCSF topped all fundraising teams for AIDS Walk San Francisco 2016, and ZSFG's Ward 86 gets $100K in proceeds. See the full story.
UCTV Profile of Diane Havlir
The work of one of the ARI's leaders is highlighted in a UCTV-produced video entitled Diane Havlir: SEARCHing for the End of AIDS.
Women's HIV Program Highlighted
The Commonwealth Fund publication Transforming Care further highlights the innovative trauma-informed work being done at the Women's HIV Program at UCSF.
Q&A about WHP's trauma-informed care
Overview on trauma's impact on health
AIDS 2016 Conference
UCSF scientists continue to be on the cutting edge of HIV/AIDS research. Read about their contributions to the AIDS 2016 conference in Durban, South Africa here.
The End of AIDS?
A new PBS Newshour series profiles initiatives that are working to end the HIV/AIDS epidemic. Watch how UCSF is involved in this bold mission here.
Reducing HIV Disparities in California
The California HIV/AIDS Research Program (CHRP) is funding 3 collaborations to reduce disparities in HIV prevention, testing and treatment in California. Read more here.
Countdown to a Cure
Spurred by three decades of momentum and fresh funding, scientists mount a major effort to finally defeat AIDS. Read the UCSF Magazine story here.
Feature on HIV Survivors
They outlived an epidemic, but San Francisco’s AIDS survivors are still fighting for their lives. Read the SF Chronicle's feature, "Last Men Standing," here.
UCSF Women's Program Featured
The UCSF Women's Program led by Dr. Edward Machtinger offers trauma-centered care to address the full range of issues impacting women living with HIV. Read the SF Chronicle article here.
UCSF Is Well Represented at CROI
View a compilation of UCSF talks and poster presentations at the 2016 CROI (Conference on Retroviruses and Opportunistic Infections) in Boston here.
$20M Grant from amfAR Funds HIV Cure Research
With $20 million over five years, the amfAR Institute for HIV Cure Research will support the work of scientists at UCSF, Gladstone, Blood Systems Research Institute and other partners at the forefront of the effort to cure AIDS. News story | Video
KQED on UCSF's Search for a Cure
Dr. Paul Volberding is featured in the KQED News story A Cure for AIDS: Scientists Say It's "On the Horizon" by Lindsey Hoshaw.
Women's HIV Program to Participate in Trauma-Informed Care Initiative
Advancing Trauma-Informed Care is a national initiative aimed at understanding how health care settings can implement trauma-informed approaches to improve patient outcomes and decrease costs. Press release
PBS Covers Getting to Zero
PBS Newshour highlights efforts of the Getting to Zero Consortium in San Francisco in the video story San Francisco bolsters anti-AIDS campaign with new funding.
HIV/AIDS Research Priorities at NIH
See the slides from this recent talk by Dr. Judith Auerbach.
Getting to Zero in SF
The New York Times ran this story about our efforts as part of the citywide Getting to Zero consortium. Full story